The most disruptive and sustainable construction meets at Tomorrow.Building World Congress

Bulding models at Tomorrow.Building
Building_at_SCEWC

Bulding models at Tomorrow.Building

BARCELONA, Spain, Oct. 25, 2023 (GLOBE NEWSWIRE) — Showcasing the most groundbreaking projects to promote innovative and sustainable construction. This is the main goal of Tomorrow.Building World Congress (TBWC), an event organized by Fira de Barcelona featuring leading companies in the transformation of the sector, as well as startups with innovative initiatives. In addition, TBWC also aims to promote debate on the future of the sector with a hundred experts who will address its challenges in decarbonisation, digitalisation and sustainable urban development.

From November 7 – 9, the event will gather some 50 companies with a disruptive spirit and a firm commitment to sustainability willing to transform the construction sector.

These include major international companies such as Samsung C&T Corporation and Siemens, leaders in the development of smart cities; Samoo Architects & Engineers, a Korean architecture firm with sustainable and efficient designs worldwide, as well as CBRE, Drees&Sommer, Johnson Controls, Roshn Group and SPIE. There will also be room for companies with innovative projects such as Bioo, which has developed an initiative to produce electricity through plant photosynthesis.

The event also aims to promote knowledge and debate in the industry on issues such as design technology, green districts, decarbonisation and PropTech, as well as issues of today’s and tomorrow’s cities, such as access to affordable and sustainable housing, urban readiness to welcome refugees and the acceleration of the energy transition.

The congress programme will feature a hundred experts including, among others, Nate Blecharczyk, Co-founder and Director of Strategy of Airbnb; Lebanese architect and specialist in Artificial Intelligence, Chantal Matar; Peter Körte, Director of Technology at Siemens; Peggy Deamer, Professor Emeritus at the Yale School of Architecture and Founder of The Architecture Lobby; Natalia Oliver, architect and specialist in BIM; and Piero Pelizzaro, Director of the National Hub for the Regeneration of Public buildings and expert in climate change policies.

In addition, FC Barcelona will present the latest details of the construction project of the new Spotify Camp Nou and its initiative for the renovation of its urban environment, Espai Barça.

Tomorrow.Building is held alongside Smart City Expo World Congress, Tomorrow.Mobility, Tomorrow.Blue Economy and PUZZLE X. Together the events will gather more than 25,000 attendees, 1,000 exhibitors, and representatives from more than 800 cities and 140 countries.

For media requests please contact:

Salvador Bilurbina
email: sbilurbina@firabarcelona.com
phone: +34628162674

A photo accompanying this announcement is available at: https://www.globenewswire.com/NewsRoom/AttachmentNg/dd5da650-0297-4005-b058-177cebdc1970

GlobeNewswire Distribution ID 1000885919

King Faisal Specialist Hospital and Research Centre ประกาศเปิดเภสัชพันธุศาสตร์คลินิกที่เป็นนวัตกรรม

ซึ่งช่วยเพิ่มประสิทธิผลของยาและความปลอดภัยของผู้ป่วย

ริยาด ซาอุดีอาระเบีย, Oct. 25, 2023 (GLOBE NEWSWIRE) — The King Faisal Specialist Hospital and Research Centre (KFSH&RC) มีความภูมิใจที่จะประกาศการเปิดตัวระยะแรกของบริการเภสัชพันธุศาสตร์ทางคลินิกภายในศูนย์หัวใจ บริการใหม่นี้ใช้ประโยชน์จาก DNA ของผู้ป่วยในการปรับแต่งขนาดยาและการเลือกใช้ยา ซึ่งถือเป็นการเริ่มศักราชใหม่ในการดูแลสุขภาพที่ให้ความสำคัญกับการรักษาเฉพาะบุคคลสำหรับแต่ละคน แนวทางที่ก้าวล้ำนี้พร้อมที่จะปรับปรุงผลการรักษาและลดอันตรายที่อาจเกิดขึ้น

ผู้เชี่ยวชาญของ KFSH&RC กล่าวว่าการวิเคราะห์นี้ช่วยให้แพทย์สามารถสั่งยาที่ปรับให้เหมาะกับผู้ป่วยแต่ละราย โดยพิจารณาจากสภาวะสุขภาพและลักษณะทางพันธุกรรมที่เป็นเอกลักษณ์ของผู้ป่วยเหล่านั้น การตอบสนองต่อยาของผู้ป่วยอาจแตกต่างกันอย่างมีนัยสำคัญขึ้นอยู่กับลักษณะทางพันธุกรรม จึงส่งผลให้สิ่งที่พิสูจน์ว่ามีประสิทธิภาพสำหรับผู้ป่วยรายหนึ่งอาจจะแทบไม่มีผลอะไรต่อผู้ป่วยอีกรายหนึ่งเลย ไม่เป็นที่น่าแปลกใจที่สถิติเผยให้เห็นว่า 15% ของการเข้ารับการรักษาในโรงพยาบาลเกิดจากปฏิกิริยาไม่พึงประสงค์จากยา ซึ่งสร้างภาระทางการเงินและภาระที่เกี่ยวข้องกับมนุษย์อย่างมากต่อระบบการดูแลสุขภาพทั่วโลก

บริการที่เป็นนวัตกรรมนี้เป็นความร่วมมือระหว่าง Center for Genomic Medicine, Healthcare Information Technology Affairs และ Pharmaceutical Care Department ที่ KFSH&RC ในระยะเริ่มแรก บริการนี้ครอบคลุมยาที่ต้องสั่งจ่ายบ่อยที่สุด 6 ชนิดตามที่กำหนดโดยข้อมูลของโรงพยาบาล ซึ่งเป็นที่ทราบกันว่าประสิทธิภาพได้รับอิทธิพลจากการเปลี่ยนแปลงทางพันธุกรรม

KFSH&RC แสดงให้เห็นชัดเจนว่ายังคงมุ่งมั่นที่จะขยายขอบเขตการบริการนี้อย่างต่อเนื่อง ซึ่งครอบคลุมทุกแผนกของโรงพยาบาล การขยายธุรกิจครั้งนี้ได้เน้นย้ำถึงความทุ่มเทอย่างแน่วแน่ของโรงพยาบาลในการให้บริการดูแลสุขภาพเฉพาะบุคคลแก่ผู้ป่วยทุกคน โดยรับประกันความปลอดภัยในระดับสูงสุด และลดอันตรายให้เหลือน้อยที่สุด ขณะเดียวกันก็ยึดมั่นในแนวทางปฏิบัติทางวิทยาศาสตร์ล่าสุดที่ได้รับการรับรองในระดับโลกด้วย

โรงพยาบาลแห่งนี้เตรียมเปิดตัวบริการที่เป็นนวัตกรรมใหม่ที่ให้คำมั่นว่าจะพัฒนาผลลัพธ์ด้านการดูแลสุขภาพในภูมิภาคที่งาน Global Health Exhibition ซึ่งจัดขึ้นที่กรุงริยาด ระหว่างวันที่ 29-31 ตุลาคม โดย KFSH&RC จะมีบทบาทสำคัญในฐานะพันธมิตรเชิงกลยุทธ์ด้านสุขภาพ

KFSH&RC ระบุว่าโรงพยาบาลกำลังค่อย ๆ ขยายขอบเขตการขอใช้บริการนี้ให้ครอบคลุมความเชี่ยวชาญทางการแพทย์ทั้งหมด ซึ่งเป็นส่วนหนึ่งของความมุ่งมั่นในการให้บริการดูแลสุขภาพส่วนบุคคลสำหรับผู้ป่วยแต่ละรายในระดับสูงสุดที่มีความปลอดภัยและป้องกันอันตรายที่อาจเกิดขึ้น และใช้ประโยชน์จากแนวทางปฏิบัติที่ได้รับการพิสูจน์ทางวิทยาศาสตร์ล่าสุดแล้วทั่วโลก

King Faisal Specialist Hospital and Research Center ถือเป็นหนึ่งในโรงพยาบาลที่โดดเด่นที่สุดในโลกในด้านการให้บริการดูแลสุขภาพเฉพาะทาง เป็นผู้บุกเบิกด้านนวัตกรรม และเป็นศูนย์การวิจัยและการศึกษาทางการแพทย์ขั้นสูง นอกจากนี้โรงพยาบาลยังมุ่งพัฒนาเทคโนโลยีทางการแพทย์และยกระดับการดูแลสุขภาพทั่วโลกโดยร่วมมือกับสถาบันท้องถิ่น ระดับภูมิภาค และระดับนานาชาติที่มีชื่อเสียงต่าง ๆ ทั้งนี้ก็เพื่อให้บรรลุการบริการระดับโลกในสาขาคลินิก การวิจัย และการศึกษา

ข้อมูลการติดต่อ:

kfshrc@mcsaatchi.com

ดูรูปภาพประกอบประกาศนี้ได้ที่ https://www.globenewswire.com/NewsRoom/AttachmentNg/9e826983-52ae-4fe5-8579-0cbdfcca9d1c

GlobeNewswire Distribution ID 8965796

LambdaTest launches Test Muting Feature to Improve Software Testing Efficiency

LambdaTest’s new Test Muting feature streamlines testing, reduces noise, and accelerates feedback, improving software testing efficiency

San Francisco, Oct. 25, 2023 (GLOBE NEWSWIRE) — LambdaTest, a leading cloud-based unified testing platform, has launched Test Muting currently in the BETA stage and is available exclusively for select customers. This strategic tool, meticulously designed to empower organizations in managing and controlling test scenarios prone to persistent failures, brings a new era of efficiency to software testing.

LambdaTest’s Test Muting feature addresses crucial needs by providing users with the ability to automatically mute troublesome tests, thus decluttering test results and enabling a sharper focus on mission-critical issues.

This feature accelerates the feedback loop, facilitating the rapid identification and management of problematic tests. Customizable thresholds offer adaptability to changing testing scenarios, while manual control ensures users have the autonomy to mute or unmute specific test cases, aligning with dynamic testing requirements. LambdaTest’s Test Muting also features a comprehensive activity history, empowering users with insights into their testing strategy’s evolution and the effectiveness of muted tests.

Mayank Bhola, Co-Founder, and Head of Product at LambdaTest said, “The Test Muting feature underscores our commitment to delivering the tools our users need to succeed in today’s dynamic testing landscape. By enhancing the efficiency of testing, it not only saves valuable time and resources but also contributes to an organization’s bottom line.”

LambdaTest’s introduction of Test Muting marks a significant step toward improving software testing efficiency and providing users with more control over their testing processes. It is set to empower select customers with the ability to streamline their testing efforts, reduce noise, and expedite feedback, reflecting LambdaTest’s commitment to delivering innovative solutions that contribute to the success of organizations in the ever-evolving landscape of software testing.

For more information on LambdaTest’s Test Muting feature, please visit https://www.lambdatest.com/support/docs/hyperexecute-test-muting/

About LambdaTest

LambdaTest is an intelligent and omnichannel enterprise execution environment that helps businesses drastically reduce time to market through Just in Time Test Orchestration (JITTO),  ensuring quality releases and accelerated digital transformation. Over 10,000+ enterprise customers and 2+ million users across 130+ countries rely on LambdaTest for their testing needs.

● Browser & App Testing Cloud allows users to run both manual and automated tests of web and mobile apps across 3000+ different browsers, real devices, and operating system environments.

● HyperExecute helps customers run and orchestrate test grids in the cloud for any framework and programming language at blazing-fast speeds to cut down on quality test time, helping developers build software faster.

For more information, please visit, https://lambdatest.com

LambdaTest press office: press@lambdatest.com

GlobeNewswire Distribution ID 8965741

General Fusion and TRIUMF sign MOU to develop key technologies for new LM26 fusion machine

RICHMOND, British Columbia, Oct. 25, 2023 (GLOBE NEWSWIRE) — TRIUMF, Canada’s particle accelerator centre, and General Fusion, an international leader in the development of commercial fusion energy, announced that they have signed a Memorandum of Understanding (MOU) that provides a framework for scientific and technical collaboration. Under the terms of the agreement, the two globally recognized B.C. innovators will work together to design diagnostics that will advance General Fusion’s technology and prove the performance of the company’s new Magnetized Target Fusion (MTF) demonstration, called Lawson Machine 26 (LM26). This groundbreaking machine is designed to reach fusion conditions in 2025 and set a path for scientific breakeven equivalent in 2026.

TRIUMF and General Fusion will collaborate on projects in key areas including neutron diagnostics and a state-of-the-art ion temperature diagnostic for LM26. The information from these diagnostics will be critical in verifying that LM26 achieves fusion conditions, reaching temperatures of more than 100 million degrees Celsius, or 10 keV, and will be used to drive General Fusion’s progress towards scientific breakeven equivalent. Additionally, the data will provide important inputs into confirming the costs and size of General Fusion’s commercial scale machine, putting the company on course to bring clean fusion energy onto the electricity grid by the early to mid-2030s.

This diagnostic work builds upon the existing relationship between TRIUMF and General Fusion that began in 2022. Incorporating TRIUMF’s expertise into General Fusion’s development of innovative technologies, from initial concepts to final design and manufacturing, will help to ensure the technology deployed is practical for commercial power plants. Moving forward, General Fusion will also leverage TRIUMF’s experience with large-scale physics machines to develop interfaces that efficiently analyze and interpret information for operators of LM26.

Quotes:

“British Columbia is a hub for technology innovation and General Fusion is pleased to advance our transformative LM26 machine with an organization that is both local and has international renown,” said Greg Twinney, CEO, General Fusion. “We look forward to drawing from TRIUMF’s deep well of knowledge and abilities to help drive toward our goal to achieve scientific breakeven by 2026.”

“TRIUMF is very pleased to be continuing our ongoing work with General Fusion and support their efforts in progressing a new form of clean energy technology,” commented Kathryn Hayashi, CEO of TRIUMF Innovations, TRIUMF’s commercialization arm. “For decades, our lab has fostered global research collaborations in innovation and science that overcome monumental barriers, and we see that same ambition and passion driving the work carried out by General Fusion. We are eager to apply our expertise and resources to help develop the technology they require to make commercial fusion power a reality.”

Quick Facts:

  • General Fusion is fast-tracking its technical progress to provide commercial fusion energy to the grid by the early to mid-2030s. The company’s new LM26 machine, being built at its Richmond headquarters, will integrate the company’s operational plasma injector with a simplified compression system.
  • The results from LM26 will validate the company’s ability to compress magnetized plasmas in a repeatable manner and achieve fusion conditions without requiring expensive superconducting magnets, or high-powered lasers. The data gathered from LM26 will then be incorporated into the design of the company’s planned commercial scale demonstration in the UK.
  • Established in Vancouver in 1968, TRIUMF has an international reputation for pushing the frontiers of science and innovation. This includes the development of technologies to address fundamental and applied problems in particle and nuclear physics, as well as the materials and life sciences.
  • General Fusion will leverage TRIUMF’s existing capabilities in high energy particle physics, materials science and testing to support the development of General Fusion’s Magnetized Target Fusion technology.

About General Fusion
General Fusion is pursuing a fast and practical approach to commercial fusion energy and is headquartered in Richmond, B.C. The company was established in 2002 and is funded by a global syndicate of leading energy venture capital firms, industry leaders and technology pioneers. Learn more at generalfusion.com.

General Fusion Media Relations
media@generalfusion.com
+1-866-904-0995

Follow General Fusion
twitter.com/generalfusion
instagram.com/generalfusion
linkedin.com/company/general-fusion
facebook.com/generalfusion
youtube.com/c/GeneralFusionInc

About TRIUMF
Established in 1968 in Vancouver, TRIUMF is Canada’s particle accelerator centre. The lab is a hub for discovery and innovation inspired by a half-century of ingenuity in answering some of nature’s most challenging questions. From the hunt for the smallest particles in our universe and the origin of the elements that make up our world to research that advances the next generation of batteries, quantum computers or cures for cancer, TRIUMF is pushing frontiers in research, while training the next generation of leaders in science, medicine, and industry.

TRIUMF Media Relations
Stu Shepherd
Head, Communications
1.604.222.7528
sshepherd@triumf.ca
@TRIUMFlab

GlobeNewswire Distribution ID 8965317

Curium and PIUR IMAGING Announce Thyroid Imaging Partnership in Germany to Enable Tomographic 3D Ultrasound Solutions

BERLIN, Oct. 25, 2023 (GLOBE NEWSWIRE) — Curium, a world leader in nuclear medicine, and PIUR IMAGING, a European medical device company at the forefront of pioneering tomographic 3D ultrasound solutions, announced today a strategic partnership to advance thyroid diagnostics in Germany.

Under the terms of the partnership agreement, PIUR IMAGING will provide and continuously develop the hardware and software solution, with Curium responsible for the exclusive distribution of the product in nuclear medicine in Germany.

Ciril Faia, CEO SPECT Europe at Curium, commented: “The partnership announced today with PIUR IMAGING in Germany represents an exciting leap forward in medical imaging, with the potential to impact cancer patient care and treatment outcomes. As we focus on redefining the experience of cancer through our trusted legacy in nuclear medicine, this partnership builds on Curium’s expertise, capacity, and global track record in the development and delivery of diagnostic and therapeutic solutions by leveraging PIUR’s ‘tUS Infinity’ AI-driven imaging.”

The PIUR tUS Infinity, offered by PIUR IMAGING, seamlessly turns standard ultrasound systems into tomographic 3D imaging devices. This solution provides healthcare professionals with full volume acquisitions and 3D analysis of the thyroid organ and potential nodules. Powered by AI-driven software for proposal of nodule classification based on ACR-TIRADS criteria and equipped with comprehensive documentation capabilities of diagnostic results, the PIUR tUS Infinity not only streamlines workflow efficiency but also enhances transparency and reproducibility, taking thyroid diagnostics to the next level.

Robert Bauer, Chief Technology Officer at PIUR IMAGING, commented, “Our collaboration with Curium is a significant milestone for PIUR and our growth in Germany. Leveraging Curium’s extensive network and our innovative tomographic 3D solution, we are poised to redefine thyroid imaging in Germany and beyond.”

For more information about PIUR IMAGING and its tomographic 3D ultrasound imaging solutions, please visit https://piurimaging.com/.

About Curium
Curium is a world leader in nuclear medicine. We develop, manufacture, and distribute world-class radiopharmaceutical products to help patients around the globe. Our proven heritage combined with a pioneering approach are the hallmarks to deliver innovation, excellence, and unparalleled service.
With manufacturing facilities across Europe and the United States, Curium delivers SPECT, PET and therapeutic radiopharmaceutical solutions for life-threatening diseases to over 14 million patients annually. The name ‘Curium’ honors the legacy of pioneering radioactive materials researchers Marie and Pierre Curie, after whom the radioactive element curium was named and emphasizes our focus on nuclear medicine. To learn more, visit www.curiumpharma.com

For more information:

Ross Bethell
VP, Head of Global Communications
communications@curiumpharma.com

About PIUR IMAGING

PIUR IMAGING is a Europe-based medical device company focused on enhancing healthcare diagnostics. Leveraging the power of AI, we specialize in tomographic 3D ultrasound imaging solutions, seamlessly integrated with existing ultrasound devices. Our advanced 3D imaging technology enables comprehensive volume measurements of entire organs and structures, significantly improving documentation, transparency, and objectivity in ultrasound examinations. With precise AI-assisted analysis and reporting, our software ensures greater reproducibility and workflow efficiency. From the diagnosis to the monitoring of thyroid nodules and various anomalies, we empower medical professionals to improve their diagnostic workflow as well as pre- and post-treatment care. For further information, visit: https://piurimaging.com/

For more information:

PIUR IMAGING
Stacey Hong
Marketing Manager
hong@piurimaging.com
+43 – 676 – 373 59 36

GlobeNewswire Distribution ID 8965595

LeddarTech Unveils LeddarCar at Reuters Automotive USA 2023 on November 8-9 in Detroit, Demonstrating Next-Gen Sensor Fusion and Perception Software for ADAS Applications

QUEBEC CITY, Oct. 25, 2023 (GLOBE NEWSWIRE) — LeddarTech®, an automotive software company that provides patented disruptive low-level sensor fusion and perception software technology for ADAS and AD, is pleased to announce its participation as a speaker and on-site exhibitor along with demonstrating its technology live with the LeddarCar at the Automotive USA 2023 conference on November 8-9, Huntington Place, Detroit, MI.

The Automotive USA 2023 event has become an industry hallmark, and this year’s edition promises to be a new milestone in automotive innovation. LeddarTech’s software solutions have received several awards and honors this year, with most recently being granted the UK-based AutoTech Breakthrough announced on October 4, 2023 that LeddarVision™ Front-Entry-Level (LVF-E) has been selected as winner of the Advanced Driver Assistance System of the Year award.

November 8-9: EXPERIENCE LeddarTech’s award-winning interactive dashboard demonstration at booth #18 featuring LeddarVision, a high-performance, scalable, cost-efficient automotive low-level sensor fusion and perception software solution that is also hardware and processor-agnostic.

Also featuring LeddarVision-inspired ADAS products:

  • LVF-E, a front-view fusion and perception stack for entry-level ADAS L2/L2+ highway assist and 5-star NCAP 2025/GSR 2022
  • LVF-H, the premium companion fusion and perception stack in the front-view product family featuring extended sensor configuration
  • LVS-2+, the newly launched surround-view premium fusion and perception stack that efficiently extends the LVF front-view product family 1VxR sensor configuration to a 5V5R configuration

RIDE ALONG LeddarCar live: Delegates representing automotive Tier 1-2 suppliers and OEMs are invited to book a real-world on-road demonstration of LeddarTech’s LeddarVision low-level fusion and perception software technology. Space is limited, so reserve your LeddarCar on-road demo now.

LeddarTech Presents: On November 9 at 1:10 p.m., Pierre Olivier, LeddarTech’s Chief Technology Officer, will host a panel discussion entitled “Delivering a Safe Transition Towards Autonomous Vehicles.” Take a seat alongside fellow auto executives to engage, build partnerships and delve into a key challenge that the market is facing!

Pre-arrange a meeting for a product demonstration or to experience LeddarCar live.

About Automotive USA 2023

“Reuters Events: Automotive USA” is the industry gathering to unite senior-level OEM leaders who address how they will build software-defined electric vehicles, reshape the OEM business model and plan for an autonomous future. Reaching a North American audience, this event shapes future strategies across business-critical topics, including electrification, connectivity, autonomous vehicles, sustainability, supply chain and more.

About LeddarTech

A global software company founded in 2007 and headquartered in Quebec City with additional R&D centers in Montreal, Toronto and Tel Aviv, Israel, LeddarTech develops and provides comprehensive perception software solutions that enable the deployment of ADAS and autonomous driving (AD) applications. LeddarTech’s automotive-grade software applies advanced AI and computer vision algorithms to generate accurate 3D models of the environment, allowing for better decision making and safer navigation. This high-performance, scalable, cost-effective technology is available to OEMs and Tier 1-2 suppliers to efficiently implement automotive and off-road vehicle ADAS solutions.

LeddarTech is responsible for several remote-sensing innovations, with over 150 patent applications (80 granted) that enhance ADAS and AD capabilities. Better awareness around the vehicle is critical in making global mobility safer, more efficient, sustainable and affordable: this is what drives LeddarTech to seek to become the most widely adopted sensor fusion and perception software solution.

Additional information about LeddarTech is accessible at www.LeddarTech.com and on LinkedIn, Twitter (X), Facebook and YouTube.

Contact:
Daniel Aitken, Vice-President, Global Marketing, Communications and Investor Relations, LeddarTech Inc. Tel.: + 1-418-653-9000 ext. 232 daniel.aitken@LeddarTech.com

Leddar, LeddarTech, LeddarVision, LeddarSP, VAYADrive, VayaVision and related logos are trademarks or registered trademarks of LeddarTech Inc. and its subsidiaries. All other brands, product names and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owners.

GlobeNewswire Distribution ID 8952473